Cefepime vs. Ceftriaxone

Attribute	Cefepime	Ceftriaxone
Drug class	Cephalosporin antibiotic	Cephalosporin antibiotic
Route of administration	IV, IM	IV, IM
Half-life	2 hours	5.8-8.7 hours
Frequency of dosing	2-3 times daily	Once daily
Common uses	Severe infections, pneumonia, UTIs	Severe infections, meningitis, gonorrhea

Introduction

Cefepime and ceftriaxone are both broad-spectrum antibiotics that belong to the cephalosporin class. They are commonly used to treat a variety of bacterial infections, including pneumonia, urinary tract infections, and skin infections. While they share some similarities, there are also key differences between the two drugs that make them unique in their own right.

Mechanism of Action

Cefepime and ceftriaxone both work by inhibiting the synthesis of the bacterial cell wall, leading to cell death. However, cefepime has a broader spectrum of activity compared to ceftriaxone, making it effective against a wider range of bacteria. Ceftriaxone, on the other hand, is more stable in the presence of beta-lactamases, enzymes produced by some bacteria that can inactivate antibiotics.

Administration

Cefepime is typically administered intravenously, either as a bolus injection or through a continuous infusion. It is important to monitor renal function in patients receiving cefepime, as the drug is primarily excreted through the kidneys. Ceftriaxone, on the other hand, can be given intravenously or intramuscularly, providing flexibility in dosing options for healthcare providers.

Side Effects

Both cefepime and ceftriaxone can cause similar side effects, including diarrhea, nausea, and allergic reactions. However, cefepime has been associated with a higher risk of neurotoxicity, particularly in patients with renal impairment. Ceftriaxone, on the other hand, has been linked to biliary sludging and gallbladder pseudolithiasis, especially when used in high doses or for prolonged periods.

Resistance

Resistance to cefepime and ceftriaxone is a growing concern in the medical community, as bacteria continue to develop mechanisms to evade the effects of these antibiotics. Cefepime resistance is often mediated by the production of extended-spectrum beta-lactamases (ESBLs), enzymes that can break down the drug and render it ineffective. Ceftriaxone resistance, on the other hand, is commonly associated with alterations in the bacterial cell wall that prevent the drug from binding to its target.

Indications

Cefepime is often used to treat serious infections caused by gram-negative bacteria, such as Pseudomonas aeruginosa and Enterobacter species. It is also effective against some gram-positive bacteria, making it a versatile choice for empiric therapy in hospitalized patients. Ceftriaxone, on the other hand, is commonly used to treat infections caused by Streptococcus pneumoniae, Neisseria gonorrhoeae, and Haemophilus influenzae, among others.

Cost

When it comes to cost, ceftriaxone is generally more affordable than cefepime. This can be an important factor to consider when choosing between the two drugs, especially in resource-limited settings or when treating large numbers of patients. However, the decision should ultimately be based on the specific clinical scenario and the susceptibility of the infecting bacteria to each antibiotic.